Doctor Pleads Guilty in Matthew Perry Death
Analysis based on 29 articles · First reported Jun 16, 2025 · Last updated Jun 17, 2025
The event highlights the risks associated with the off-label use and illegal distribution of drugs like Ketamine, potentially leading to increased scrutiny and regulation in the pharmaceutical and healthcare industries. While not directly impacting stock prices, it underscores the importance of ethical medical practices and drug control, which can influence investor confidence in related sectors.
Dr. Salvador Plasencia, a doctor, has agreed to plead guilty to four counts of ketamine distribution in connection with the death of actor Matthew Perry. Perry died in October 2023 from acute ketamine effects. Plasencia illegally supplied Matthew Perry with 20 vials of ketamine, lozenges, and syringes, sometimes injecting him at his home or in a parking lot. He also enlisted another doctor, Adema, to acquire more of the drug. Court documents reveal Plasencia referred to Matthew Perry as a 'moron' who could be exploited for money. Plasencia faces a maximum sentence of 40 years in prison. Other individuals, including Jasveen Sangha, accused of being a major ketamine dealer and supplying the fatal dose, and Matthew Perry's assistant Kenneth Iwamasa, and friend Erik Fleming, have also been charged, with most having pleaded guilty and cooperating with authorities. Jasveen Sangha is the only defendant who has pleaded not guilty and awaits trial.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard